Can intravenous cefuroxime be used for an adult with mastoiditis, and what is the appropriate weight‑based dosing?

Can IV Cefuroxime Be Used for Mastoiditis and What is the Weight-Based Dosing?

Yes, IV cefuroxime can be used for mastoiditis, though it is not the first-line agent recommended by WHO guidelines, which prioritize cloxacillin/flucloxacillin with ceftriaxone as second-line. However, cefuroxime is an acceptable alternative based on FDA-approved dosing and its spectrum of activity against the typical mastoiditis pathogens (Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae).

Weight-Based Dosing for IV Cefuroxime

Pediatric Patients (>3 months old)

• Standard infections: 50-100 mg/kg/day divided every 6-8 hours 1
• Severe infections (including bone infections like mastoiditis): 100 mg/kg/day divided every 6-8 hours, not to exceed maximum adult dosage 1
• Bone and joint infections specifically: 150 mg/kg/day divided every 8 hours, not to exceed maximum adult dosage 1

Adults

• Standard dosing: 750 mg to 1.5 grams every 8 hours 1
• Severe/complicated infections: 1.5 grams every 8 hours 1
• Life-threatening infections: 1.5 grams every 6 hours may be required 1

Practical Dosing Approach

For mastoiditis specifically, I would recommend:

• Children: Start with 100 mg/kg/day divided every 8 hours (approximately 33 mg/kg per dose) given the severity of mastoiditis as a bone infection
• Adults: 1.5 grams every 8 hours for adequate bone penetration

Clinical Context and Caveats

Important considerations:

1. First-line therapy differs: The WHO Pocket Book recommends cloxacillin/flucloxacillin 50 mg/kg QDS (four times daily) for 10 days as first-line for mastoiditis, with ceftriaxone as second-line 2. Cefuroxime would be an alternative if these agents are unavailable or contraindicated.

2. Duration: Mastoiditis typically requires 10 days of IV therapy 2, though recent evidence suggests uncomplicated cases may respond to shorter courses with close monitoring 3.

3. Renal adjustment: Reduce dosing frequency in renal impairment (CrCl <20 mL/min: give every 12 hours; CrCl <10 mL/min: give every 24 hours) 1

4. Surgical drainage: If there is evidence of subperiosteal abscess, coalescence, or bony erosion, surgical intervention (myringotomy ± mastoidectomy) should be considered alongside antibiotics 4, 3. Medical management alone is appropriate only for truly uncomplicated mastoiditis without bony erosion 3.

5. MRSA coverage: If MRSA is suspected (prior hospitalization, known colonization, or failure to respond), cefuroxime is inadequate and vancomycin should be added 5

6. Pharmacodynamic target: Cefuroxime achieves therapeutic concentrations in bone tissue when dosed appropriately 6. The goal is maintaining time above MIC (T>MIC) >50% of the dosing interval, which is achieved with the recommended dosing 7.